K-RAS GENE MUTATION IN GALL-BLADDER CARCINOMAS AND DYSPLASIA

Citation
T. Ajiki et al., K-RAS GENE MUTATION IN GALL-BLADDER CARCINOMAS AND DYSPLASIA, Gut, 38(3), 1996, pp. 426-429
Citations number
24
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
GutACNP
ISSN journal
00175749
Volume
38
Issue
3
Year of publication
1996
Pages
426 - 429
Database
ISI
SICI code
0017-5749(1996)38:3<426:KGMIGC>2.0.ZU;2-9
Abstract
Epithelial dysplasia of gall bladder is an important precancerous lesi on of gall bladder carcinogenesis. To investigate the frequency of K-r as gene mutation in gall bladder carcinoma and dysplasia, K-ras codon 12 mutations were investigated by the polymerase chain reaction/restri ction enzyme based method following direct sequencing. Mutation was de tected in 59% (30 of 51) of gall bladder carcinomas, in 73% (8 of 11) of gall bladder dysplasia in gall stone cases, and in 0% of the normal gall bladder epithelium. There was, however, no correlation between K -ras mutation and clinicopathological factors of gall bladder carcinom a. K-ras gene mutation occurs even in gall bladder dysplasia at an inc idence similar to that in carcinomas, suggesting that testing for K-ra s gene mutation may prove useful as an adjunct to bile cytological or biopsy analysis.